{
    "id": "nclex-ngn-sa-ps-2026-041",
    "itemType": "standalone_multipleChoice",
    "prompt": "The nurse is reviewing the electronic health record for a client in the emergency department. Based on the provided information, which action should the nurse perform first?",
    "stem": {
        "sections": [
            {
                "type": "nursesNotes",
                "title": "Nurses' Notes",
                "content": "Client is a 68-year-old male with a history of end-stage renal disease (ESRD) on hemodialysis, hypertension, and type 2 diabetes mellitus. Arrived via ambulance with chief complaints of profound muscle weakness, palpitations, and nausea over the last 12 hours. Client is alert and oriented x3 but appears lethargic. Reports missing the last two scheduled hemodialysis appointments due to a lack of reliable transportation. A 20-gauge peripheral intravenous (PIV) catheter was placed in the left forearm by paramedics; it flushes sluggishly, and mild swelling is noted proximal to the site."
            },
            {
                "type": "table",
                "title": "Vital Signs Trend",
                "columns": [
                    "Time",
                    "BP",
                    "HR",
                    "RR",
                    "Temp",
                    "SpO2"
                ],
                "rows": [
                    [
                        "1300",
                        "110/70",
                        "62",
                        "18",
                        "37.0째C (98.6째F)",
                        "97%"
                    ],
                    [
                        "1330",
                        "98/60",
                        "54",
                        "20",
                        "37.1째C (98.8째F)",
                        "96%"
                    ]
                ]
            },
            {
                "type": "table",
                "title": "Laboratory Results",
                "columns": [
                    "Test",
                    "Result",
                    "Reference Range"
                ],
                "rows": [
                    [
                        "Potassium",
                        "7.1 mEq/L",
                        "3.5-5.0 mEq/L"
                    ],
                    [
                        "Creatinine",
                        "8.9 mg/dL",
                        "0.6-1.2 mg/dL"
                    ],
                    [
                        "BUN",
                        "95 mg/dL",
                        "7-20 mg/dL"
                    ],
                    [
                        "Troponin I",
                        "<0.02 ng/mL",
                        "<0.04 ng/mL"
                    ]
                ]
            },
            {
                "type": "text",
                "title": "Diagnostic Findings",
                "content": "12-Lead ECG Interpretation: Sinus bradycardia with prominent peaked T waves, QRS duration of 0.14 seconds, and a PR interval of 0.22 seconds."
            },
            {
                "type": "text",
                "title": "Medication Administration Record (MAR)",
                "content": "STAT Orders:\n- Calcium gluconate 1 gram IV push over 5 minutes\n- Insulin, Regular 10 units IV push\n- Dextrose 50% 25 grams IV push\n- Sodium polystyrene sulfonate 30 grams orally"
            }
        ]
    },
    "options": [
        {
            "label": "D",
            "content": "Establish a new, large-bore peripheral IV line."
        },
        {
            "label": "A",
            "content": "Administer the prescribed calcium gluconate IV push."
        },
        {
            "label": "B",
            "content": "Administer the sodium polystyrene sulfonate orally."
        },
        {
            "label": "C",
            "content": "Prepare the regular insulin and D50W for administration."
        }
    ],
    "correctAnswer": "D",
    "rationale": {
        "correct": "The client is experiencing life-threatening cardiotoxicity from severe hyperkalemia, evidenced by ECG changes (peaked T waves, widened QRS, bradycardia) and hemodynamic instability (hypotension). The priority pharmacological intervention is calcium gluconate to stabilize the cardiac membrane. However, the nurse's assessment reveals the only existing peripheral IV is compromised (sluggish, swollen), indicating a high risk for infiltration or extravasation. Calcium gluconate is a potent vesicant that can cause severe tissue necrosis if it extravasates. Therefore, the absolute first and most critical safety action is to establish new, reliable, large-bore intravenous access to ensure the safe administration of this and other emergency medications. Proceeding with the current IV would be a breach of safety standards and constitutes a critical 'Don't Proceed' moment.",
        "incorrect": "This question tests the nurse's ability to recognize a critical procedural contraindication ('Safety Stop') before implementing a life-saving order. While the pharmacological priorities are correct, they cannot be safely executed without addressing the compromised IV access first. The other options either represent unsafe actions or are lower priority than securing safe IV access.",
        "answerBreakdown": [
            {
                "label": "A",
                "content": "Administering calcium gluconate is the correct pharmacological priority to prevent fatal dysrhythmias. However, doing so through a non-patent, potentially infiltrated IV is extremely dangerous. This is an unsafe action due to the high risk of extravasation and subsequent chemical burn and tissue necrosis.",
                "isCorrect": false
            },
            {
                "label": "B",
                "content": "Sodium polystyrene sulfonate is a potassium-binding resin that promotes the excretion of potassium from the body. While a part of the overall treatment plan, it has a very slow onset of action (hours) and is not appropriate for treating acute, life-threatening cardiotoxicity. Myocardial stabilization and intracellular potassium shifting are the immediate priorities.",
                "isCorrect": false
            },
            {
                "label": "C",
                "content": "Administering IV insulin and dextrose is the next step after myocardial stabilization to shift potassium from the extracellular to the intracellular space, thereby lowering the serum potassium level. While crucial, this action is secondary to administering calcium and also requires a patent IV line, which is not currently available.",
                "isCorrect": false
            },
            {
                "label": "D",
                "content": "This is the correct first action. All prescribed STAT intravenous medications (calcium gluconate, insulin, dextrose) require a reliable, patent IV line for safe and effective administration. Recognizing that the current IV access is compromised and taking action to correct this foundational problem is the nurse's immediate priority to ensure patient safety before any medications can be given.",
                "isCorrect": true
            }
        ]
    },
    "pedagogy": {
        "bloomLevel": "Analyze",
        "cjmmStep": "Take Actions",
        "nclexCategory": "Management of Care",
        "nclexSubcategory": "Establishing Priorities",
        "difficulty": "Level 5 (Highly Discriminating)",
        "topicTags": [
            "Hyperkalemia",
            "IV Therapy",
            "Medication Safety",
            "Chronic Kidney Disease",
            "Electrolyte Imbalance",
            "Patient Safety",
            "Social Determinants of Health"
        ]
    }
}